No abstract available
MeSH terms
-
Anticoagulants / therapeutic use
-
Benzimidazoles / adverse effects
-
Benzimidazoles / therapeutic use*
-
Dabigatran
-
Drug Approval*
-
Europe
-
Fibrinolytic Agents / adverse effects
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Morpholines / adverse effects
-
Morpholines / therapeutic use*
-
Pyrazoles / adverse effects
-
Pyrazoles / therapeutic use*
-
Pyridones / adverse effects
-
Pyridones / therapeutic use*
-
Rivaroxaban
-
Thiophenes / adverse effects
-
Thiophenes / therapeutic use*
-
beta-Alanine / adverse effects
-
beta-Alanine / analogs & derivatives*
-
beta-Alanine / therapeutic use
Substances
-
Anticoagulants
-
Benzimidazoles
-
Fibrinolytic Agents
-
Morpholines
-
Pyrazoles
-
Pyridones
-
Thiophenes
-
beta-Alanine
-
apixaban
-
Rivaroxaban
-
Dabigatran